Numerous in vitro experimental studies have documented the mitogenic and antiapoptotic activity resulting from the activation of the NGF-TrkA signaling pathway in murine osteoblast cell lines and human sarcoma cell lines, confirming that this pathway can contribute to the proliferation and survival of canine OSA cells in local and metastatic tumor microenvironments. The gene discussed is NTRK1; the disease is sarcoma.